Recent studies have revealed that newly emerging transformed cells are often apically extruded from epithelial tissues. During this process, normal epithelial cells can recognize and actively eliminate transformed cells, a process called epithelial defence against cancer (EDAC). Here, we show that mitochondrial membrane potential is diminished in RasV12-transformed cells when they are surrounded by normal cells. In addition, glucose uptake is elevated, leading to higher lactate production. The mitochondrial dysfunction is driven by upregulation of pyruvate dehydrogenase kinase 4 (PDK4), which positively regulates elimination of RasV12-transformed cells. Furthermore, EDAC from the surrounding normal cells, involving filamin, drives the Warburg-effect-like metabolic alteration. Moreover, using a cell-competition mouse model, we demonstrate that PDK-mediated metabolic changes promote the elimination of RasV12-transformed cells from intestinal epithelia. These data indicate that non-cell-autonomous metabolic modulation is a crucial regulator for cell competition, shedding light on the unexplored events at the initial stage of carcinogenesis.
It remains enigmatic what happens at the initial stage of carcinogenesis, where oncogenic transformation occurs in a single cell within the epithelium [1] [2] [3] . Recent studies have demonstrated that newly emerging transformed cells are often eliminated from epithelial tissues via cell competition against the neighbouring normal epithelial cells. Cell competition is a process by which two different cell populations, upon interaction, compete with each other for survival and space; consequently, the loser cells are eliminated from the tissues, while the winner cells occupy the vacant spaces. This phenomenon was originally found and has been extensively studied in Drosophila [4] [5] [6] [7] [8] [9] . However, recent studies have revealed that cell competition can also occur in mammals between normal and various types of transformed epithelial cells. For example, RasV12-, Src-or erbB2-transformed cells are apically extruded when they are surrounded by normal epithelial cells [10] [11] [12] [13] . In addition, tumour suppressor protein scribbleor mahjong-knockdown cells undergo apoptosis and leave a monolayer of normal epithelial cells 7, 14 . Importantly, when transformed cells alone are present, neither apical extrusion nor apoptosis occurs, indicating that the presence of the surrounding normal cells profoundly influences the behaviour and fate of transformed cells.
We and other groups have explored the molecular mechanisms of cell competition between normal and RasV12-transformed epithelial cells and revealed that various non-cell-autonomous changes occur in both cells at their interface. For instance, normal epithelial cells accumulate the cytoskeletal protein filamin at the interface with the adjacent transformed cells, thereby actively eliminating them 15 . This implies a notion that normal epithelial cells have anti-tumour activity that does not involve immune cells: a process termed EDAC (epithelial defence against cancer) 15 . By contrast, in RasV12-transformed cells that are surrounded by normal cells, the actin-binding protein epithelial protein lost in neoplasm (EPLIN) is accumulated 16 . The accumulated EPLIN then activates the downstream molecules such as protein kinase A (PKA) and myosin II, which positively regulate apical extrusion of RasV12 cells. However, the molecular mechanisms of how EDAC from normal cells affects the neighbouring transformed cells and promotes their elimination are still poorly understood.
Cellular metabolism is dynamically modulated and adjusted in accordance with various conditions. For example, at the later stage of cancer development, aerobic glycolysis is enhanced in tumour cells, often accompanied by the downregulation of mitochondrial activity; these metabolic changes are called the Warburg effect [17] [18] [19] [20] [21] . However, it is not clearly understood whether cellular metabolism is also affected at the initial stage of carcinogenesis. In this study, we have examined whether and how the metabolic status is regulated at the interface between normal and newly emerging transformed epithelial cells.
RESULTS

Warburg-effect-like metabolic changes occur in RasV12-transformed cells that are surrounded by normal cells
To examine the involvement of metabolic regulation in cell competition, we first examined mitochondrial energy metabolism at the interface between normal and RasV12-transformed epithelial cells. TMRM (tetramethylrhodamine methyl ester) is a positively charged red fluorescent dye that accumulates in active mitochondria according to the negative membrane potential gradient across their inner membranes. We found that the TMRM fluorescence, but not the fluorescence of a control dye CMTPX, was strongly reduced in RasV12-transformed epithelial cells surrounded by normal epithelial cells when compared with that in RasV12-transformed cells cultured alone or in green fluorescent protein (GFP)-expressing cells surrounded by normal cells (Fig. 1a-c,g ). A comparable phenomenon was also observed in Srctransformed cells, but not in scribble-knockdown cells (Supplementary Fig. 1a,b) . The decreased incorporation of TMRM was observed in both apically extruding and extruded RasV12 cells (Fig. 1d) . The mix ratio of normal and RasV12 cells affected the TMRM incorporation in RasV12 cells; the decreased TMRM incorporation was clearly observed at 50:1 or 10:1, but occurred less frequently at 4:1 or 1:1. This is compatible with the previous report demonstrating that the proportion of winner-loser cells profoundly influences the occurrence of cell competition 22 . The non-cell-autonomous downregulation of mitochondrial membrane potential was also confirmed by using MitoSOX, an indicator for mitochondrial superoxide production that reflects mitochondrial ATP production ( Fig. 1e-g ). Immunofluorescence of the mitochondrial resident protein Tom20 or MitoTracker Green fluorescence, which is incorporated into mitochondria in a membrane-potential-independent manner, showed that the number of mitochondria was not altered in RasV12 cells surrounded by normal cells (Fig. 1h and Supplementary Fig. 1c-h ). In addition, by electron microscopic analyses, mitophagosome-like structures were frequently observed in RasV12 cells that were surrounded by normal epithelial cells ( Supplementary Fig. 2 ). Collectively, these data imply that the decreased TMRM incorporation results not from a change in mitochondrial mass, but from a change in mitochondrial function. Furthermore, we found that incorporation of the glucose analogue 2-deoxy-2-[(7-nitro-2,1,3-benzoxadiazol-4-yl) amino]-D-glucose (2-NBDG) was enhanced in RasV12 cells surrounded by normal cells (Fig. 2a,b) , suggesting that uptake of glucose is enhanced in a non-cell-autonomous fashion. Moreover, expression of lactate dehydrogenase A (LDHA), which converts pyruvate to lactate, was significantly increased in RasV12-transformed cells that were surrounded by normal cells (Fig. 2c-e and Supplementary  Fig. 3a) . Accordingly, lactate secretion was higher in RasV12 cells than normal cells, and was further enhanced when RasV12 cells were surrounded by normal cells (Fig. 2f) . This non-cell-autonomous increase in lactate secretion was abolished when LDHA was knocked down in RasV12 cells ( Fig. 2f and Supplementary Fig. 4e ). These data indicate that the interaction with the neighbouring normal epithelial cells potentiates the Warburg-effect-like metabolic changes in transformed cells: downregulation of mitochondrial function and enhanced aerobic glycolysis.
PDK4 plays a crucial role in the decreased mitochondrial membrane potential and apical extrusion of RasV12-transformed cells surrounded by normal cells
To reveal the molecular mechanism that causes the Warburg-effectlike phenomenon, we examined expression of various metabolic enzymes by quantitative real-time PCR (qrtPCR) and found that expression of pyruvate dehydrogenase kinase 4 (PDK4) was significantly elevated in RasV12-transformed cells when they were co-cultured with normal cells (Fig. 3a) . PDK4 phosphorylates and thus inactivates pyruvate dehydrogenase (PDH), which catalyses conversion of pyruvate to acetyl-CoA, thereby blocking the entry into the tricarboxylic acid cycle ( Supplementary Fig. 3a) . Indeed, phosphorylation of PDH was also enhanced in RasV12 cells when they were surrounded by normal cells (Fig. 3b-d) . To examine the functional involvement of PDK4, we established RasV12-transformed cells stably expressing PDK4 short hairpin RNA (shRNA) (Fig. 3e) and CRISPR-edited PDK4-knockout RasV12-transformed cells (Supplementary Fig. 3b) . PDK4 knockdown or knockout suppressed PDH phosphorylation and significantly restored TMRM incorporation in RasV12 cells surrounded by normal cells (Fig. 3f,g and Supplementary  Fig. 3c-g ), suggesting that upregulation of PDK4 is, at least partly, responsible for the decreased mitochondrial membrane potential. PDK4 knockdown or knockout also suppressed LDHA accumulation ( Supplementary Fig. 3h-j) . Interestingly, PDK4 knockdown or (h) Immunofluorescence images of Tom20. MDCK-pTR GFP-RasV12 cells were mixed with normal MDCK cells or cultured alone, and were stained with Hoechst 33342 (blue) and anti-Tom20 antibody (red). Scale bars, 10 µm (a,c-e,h). Statistics source data for b,f are provided in Supplementary Table 2 .
knockout drastically suppressed apical extrusion of RasV12 cells, while promoting formation of basal protrusions that extended beneath the neighbouring normal cells (Fig. 3h,i and Supplementary Fig. 3k -n).
Dichloroacetate (DCA) is a specific inhibitor of the PDK family 23, 24 , of which upregulation is often observed in the late stage of cancer [25] [26] [27] [28] . Therefore, DCA has been intensively tested in clinical trials for treatment of malignant cancer including glioblastoma and various solid tumours [29] [30] [31] [32] . We found that treatment of DCA caused an effect comparable to that induced by PDK4 knockdown or knockout: suppression of PDH phosphorylation (Fig. 4a) , restoration of TMRM incorporation (Fig. 4b,c) and suppression of apical extrusion and promotion of basal protrusions (Fig. 4d,e) . We also demonstrated that another PDK inhibitor, radicicol, phenocopied the effect of DCA ( Supplementary Fig. 4a-d) . DCA treatment also suppressed elevated LDHA expression in RasV12 cells surrounded by normal cells (Fig. 4a) . In contrast, knockdown of LDHA in RasV12 cells did not affect TMRM incorporation ( Supplementary Fig. 4e,f) , suggesting that decreased mitochondrial membrane potential causes LDHA Data are mean ± s.e.m. * P < 0.05, unpaired two-tailed t-test; n = three independent experiments. Statistics source data for c,e are provided in Supplementary Table 2. upregulation. Moreover, knockdown of LDHA moderately suppressed apical extrusion ( Supplementary Fig. 4g ). These results imply that the PDK4-mediated Warburg-effect-like metabolic alteration influences the behaviour of transformed cells and promotes their elimination from epithelia. When PDH-knockdown cells were surrounded by normal cells, apical extrusion did not occur (Supplementary Fig. 4h -j), indicating that downregulation of mitochondrial membrane potential alone is not sufficient to cause apical extrusion. Thus, while the noncell-autonomously induced metabolic changes play an indispensable role in the elimination of transformed cells, additional, unidentified molecular mechanisms, which need to be explored in future studies, are also involved in this process.
EDAC and EPLIN act upstream of the Warburg-effect-like metabolic changes in RasV12 cells surrounded by normal cells
We further examined the molecular mechanism underlying the Warburg-effect-like phenomenon. In a previous study, we demonstrated that EPLIN accumulates in RasV12-transformed cells surrounded by normal cells and plays a positive role in the apical extrusion via activation of the downstream molecules PKA and myosin II (ref. 16 ). We found that knockdown of EPLIN in RasV12 cells significantly restored mitochondrial membrane potential (Fig. 5a ,b and Supplementary Fig. 5a ). In addition, EPLIN knockdown suppressed PDK4 upregulation, phosphorylation of PDH and LDHA accumulation (Fig. 5c,d and Supplementary Fig. 5b ). These data indicate that EPLIN is a crucial upstream regulator of the Warburgeffect-like metabolic changes. Furthermore, we examined the effect of various inhibitors on TMRM incorporation and apical extrusion. Concerning downstream molecules of EPLIN, the PKA inhibitor KT5720 reverted TMRM incorporation, whereas the myosin II inhibitor blebbistatin did not (Supplementary Figs 5c and 8a). The other tested inhibitors (cytochalasin D, NAC, 3-MA, Y27632, L-NAME) did not affect TMRM incorporation (Supplementary Figs 5c and 8a), indicating the specific effect of KT5720 on TMRM incorporation. Furthermore, KT5720 did not significantly affect expression of PDK4. These data suggest that EPLIN regulates those metabolic changes via PDK4-and PKA-dependent pathways ( Supplementary Fig. 8c ). It was previously reported that normal epithelial cells can recognize and actively eliminate the neighbouring transformed cells, in which filamin in the normal cells plays an important role, at least partly, by inducing the accumulation of EPLIN in transformed cells 15, 16 ; this tumour-suppressing process is called EDAC Fig. 8c ).
Upregulation of the glycolytic pathway plays a positive role in the elimination of RasV12-transformed cells
What is the functional significance of EDAC-induced Warburg-effectlike metabolic changes in the apical elimination of transformed cells? The metabolic shift from mitochondrial oxidative phosphorylation to glycolysis can affect various cellular processes, such as glucose metabolism, ATP production and resistance to reactive oxygen species (ROS)-mediated oxidative stress. Using a glucose FRET (fluorescence resonance energy transfer) probe, we found that intracellular glucose concentration was substantially diminished in RasV12 cells surrounded by normal cells (Fig. 6a-c) , indicating that intracellular glucose is exhausted via massively elevated glycolysis despite the increased glucose uptake (Fig. 2a,b) . The comparable glucose metabolic condition is also reported in the conventional Warburg effect [33] [34] [35] . In addition, the result with the FRET-based ATP sensor (ATeam) showed that the ATP level was moderately increased in RasV12-transformed cells that were surrounded by normal cells (Supplementary Fig. 5d-f) , suggesting that the ATP production is fully compensated and even promoted by the enhanced glycolytic pathway. To further understand the functional significance of this process, we examined the effect of a hexokinase inhibitor, 2-deoxy-D-glucose (2-DG). Addition of 2-DG diminished the noncell-autonomously upregulated ATP level ( Supplementary Fig. 5e-g ) and significantly suppressed apical extrusion of RasV12 cells surrounded by normal cells (Supplementary Fig. 5h,i) , indicating that the upregulation of the glycolytic pathway plays a positive role in the elimination of transformed cells. The ATP production speed via glycolysis is far greater than that via mitochondria 36 , hence the metabolic shift to glycolysis may be of benefit to transformed cells by supporting the prompt energy supply required for the dynamic process of apical extrusion. Note that 2-DG could inhibit both oxidative and fermentative glucose metabolism. To further clarify the metabolic alterations during apical extrusion, additional experiments are required in future studies.
PDK-mediated mitochondrial dysfunction induces apical elimination of RasV12-transformed cells ex vivo and in vivo
To understand the generality and functional significance of these findings, we established an LSL-RasV12-IRES-eGFP mouse whereby RasV12 expression is induced in a Cre-dependent fashion and traced by simultaneous expression of enhanced GFP (eGFP) ( Supplementary  Fig. 6a,b) . By crossing a villin-Cre-ERT2 mouse with an LSL-RasV12-IRES-eGFP mouse, we obtained a cell-competition mouse model (Fig. 7a) . Administration of a low dose of tamoxifen induces recombination events less frequently, resulting in expression of RasV12 in a mosaic manner within intestinal epithelia ( Supplementary Fig. 6c ). Using this system, we examined the fate of newly emerging RasV12-transformed cells that are surrounded by normal epithelial cells ex vivo and in vivo. First, intestinal epithelial cells were collected from these mice and were subjected to crypt organoid culture in Matrigel, followed by tamoxifen treatment 37 . At 12-24 h after treatment with a low dose of tamoxifen, RasV12-expressing cells were apically shifted with wedge-like morphology; at 36-48 h, RasV12 cells were detached from the basement membrane and eventually extruded into the apical lumen (Fig. 7b, top) . In contrast, cells expressing only GFP remained within the epithelium, and apical extrusion did not frequently occur (Fig. 7b, bottom) . When RasV12 was predominantly expressed in the whole epithelium by a high dose of tamoxifen, the frequency of apical extrusion was strongly suppressed (Fig. 7c) , indicating that the presence of the surrounding normal cells induced the elimination of transformed cells in the ex vivo system as well. We also found that EPLIN was accumulated in RasV12 cells surrounded by normal cells in a non-cell-autonomous fashion ( Supplementary Fig. 7a ). Timelapse analyses of the crypt organoid culture revealed that the event CAG promoter STOP (h) Quantification of the effect of DCA on apical extrusion ex vivo. Data are mean ± s.e.m. * P < 0.005, unpaired two-tailed t-test; n = two or three independent experiments. Statistics source data for b,c,e,h are provided in Supplementary Table 2. of apical extrusion took rather variable times between 2 and 20 h and that the extruded transformed cells disappeared into the apical lumen ( Supplementary Fig. 7b and Supplementary Videos 1-3) . Thus, we have successfully established a mouse model system, in which apical elimination of RasV12-transformed cells can be captured three dimensionally. Using this experimental system, we found that TMRM incorporation was diminished in both extruding and extruded RasV12-expressing cells that were surrounded by normal cells (Fig. 7d , first and second upper panels, e), but not in RasV12-expressing cells surrounded by one another or in GFP-expressing cells (Fig. 7d , (k) Quantification of the apical and basal extrusion of RasV12-transformed cells. Data are mean ± s.e.m. * P < 0.01, unpaired two-tailed t-test; n = three independent experiments. For i, an unprocessed original scan of the blot is shown in Supplementary Fig. 9 . Statistics source data for c,f,k are provided in Supplementary Table 2. third and fourth panels, e). In addition, phosphorylation of PDH was elevated in RasV12 cells surrounded by normal cells (Fig. 7f) . Furthermore, DCA treatment restored the TMRM incorporation and suppressed the apical extrusion of RasV12 cells (Fig. 7g,h and Supplementary Fig. 7c,d ). Finally, we examined the fate of RasV12-transformed cells in vivo. Intraperitoneal injection of a low dose of tamoxifen induced RasV12 expression in a mosaic manner within the intestinal epithelium, and most of the RasV12-expressing cells were apically eliminated after 3 days of tamoxifen treatment, whereas GFPexpressing cells remained in the epithelial layer (Fig. 8a-c) . Using twophoton microscopic in vivo time-lapse imaging, the dynamic mode of apical extrusion of RasV12-expressing cells was captured (Fig. 8d and Supplementary Video 4). Finally, we examined the functional role of PDK in the elimination of RasV12 cells from epithelia in vivo. When DCA was administered, apical extrusion of RasV12 cells was significantly suppressed (Fig. 8e,f) . Furthermore, we used the recently established iGT (intestine-specific gene transfer) system, where mouse intestinal epithelia can be transfected with short interfering RNA (siRNA) using HVJ-E (haemagglutinating virus of Japan envelope) (Fig. 8g,h ) 38 . We then demonstrated that knockdown of PDK4 significantly suppressed apical extrusion (Fig. 8i-k) . Collectively, these data suggest that apical elimination of RasV12-transformed cells occurs ex vivo and in vivo, and is promoted by the PDK4-mediated mitochondrial downregulation.
CAG-LSL-RasV12-IRES-eGFP
DISCUSSION
The glycolytic pathway and mitochondrial function are frequently deregulated in neoplastic cells in various ways. These metabolic alterations are generally thought to promote cancer progression, though its biological and pathological significance still remains elusive [17] [18] [19] [20] . Indeed, clinical trials targeting derailed mitochondrial metabolism, such as with DCA, are currently underway [29] [30] [31] [32] . By contrast, our study suggests that the Warburg-effect-like metabolic changes can occur at the early stage of carcinogenesis in a non-cell-autonomous fashion and that DCA treatment could potentially suppress eradication of newly emerging transformed cells. Thus, the adverse effect of DCA may need to be carefully re-examined for the longer time periods.
The EDAC-mediated Warburg-effect-like metabolic shift does not accommodate several features of the prevailing Warburg effect (Supplementary Fig. 8b) . The conventional Warburg effect, which is often observed in a relatively late phase of cancer progression, is caused by various genetic and epigenetic insults and adaptation to harsh tumour microenvironments. In contrast, EDAC-induced Warburg-effect-like metabolic changes are triggered by the inputs from neighbouring normal cells at the initial stage of carcinogenesis. The conventional Warburg effect is generally associated with upregulation of HIF1, PDK1/3 and PKM2 (refs 39-46), whereas in EDAC-induced Warburg-effectlike metabolic changes the expression of these enzymes is not elevated; instead, EPLIN and PDK4 act as key upstream regulators. Moreover, the most crucial difference between the conventional Warburg effect and EDAC-induced metabolic changes is their roles in tumorigenesis: the former generally plays a tumour-promoting role, whereas the latter potentially plays a tumour-suppressive role by actively eliminating transformed cells. Thus, though these two processes have similar metabolic alterations (mitochondrial downregulation and increased aerobic glycolysis), they are governed by distinct upstream and downstream mediators.
HIF1 is a crucial regulator for the Warburg effect by modulating multiple metabolic pathways, including the tricarboxylic acid cycle and glycolytic pathway 47 . Therefore, we explored the involvement of HIF1 in EDAC-induced Warburg-effect-like metabolic changes. By using the 5×HRE (HIF1-responsive element) reporter assay, we found that HIF1 activity was not enhanced in RasV12 cells surrounded by normal cells, compared with that in RasV12 cells cultured alone (Supplementary Fig. 7e ). It has been reported that HIF1 enhances transcription of PDK1/3 and LDHA, therebyinducing the Warburg effect 47 . However, qrtPCR analysis demonstrated that the messenger RNA level of PDK1/3 or LDHA was not increased in RasV12 cells surrounded by normal cells (Fig. 3a) . Thus, we could not obtain evidence showing the involvement of HIF1 in EDAC-induced metabolic changes, and our data suggest that LDHA is post-transcriptionally upregulated by an HIF1-independent, unknown mechanism.
Here, we have mainly used fluorescence imaging to demonstrate the non-cell-autonomous changes between normal and transformed epithelial cells. In the research field of cell competition, researchers have struggled with the technical problem of biochemical analyses of each cell population in co-cultures. The non-cell-autonomous changes induced by the neighbouring normal cells are regulated temporally and dynamically, thus once the interaction with normal cells is disrupted the non-cell-autonomous biochemical changes (not the mRNA level) will instantly vanish. To perform biochemical analyses for each cell population, the co-cultured epithelial cells should be first treated with trypsin to disrupt cell-cell adhesions and dissociate cells from each other, which will then be fluorescence-activated cell sorting (FACS) sorted for a few hours. Despite the substantial number of trials, we have found just minor remaining non-cell-autonomous traces after these procedures. To further intensify the findings in this study, we need to exploit new methods such as FRET probes for metabolites in future studies.
A previous study in Drosophila has shown that mitochondrial metabolism can be regulated during cell competition 48 . Our data in this study demonstrate that metabolic modulation is a crucial regulator for cell competition between normal and transformed epithelial cells in mammals as well. Further elucidation of the molecular mechanisms that drive the EDAC-induced metabolic changes will lead to novel approaches for cancer prevention.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of this paper. and chrysin (100 µM) were from Calbiochem. L-NAME (300 µM) was from Santa Cruz, and cytochalasin D (4 µM), NAC (5 mM), 2-DG (25 mM) and DCA (25 mM except for Fig. 7g,h and Supplementary Fig. 7c,d where 50 mM was used) were from Sigma-Aldrich.
Cell culture. MDCK cell lines were used in this study. The parental MDCK cell was a gift from Walter Birchmeier. The cell line was not found in the database of commonly misidentified cell lines that is maintained by ICLAC and NCBI BioXample. Mycoplasma contamination is regularly tested for all cell lines in use using a commercially available kit (MycoAlert, Lonza). The cell lines were not further authenticated. MDCK, MDCK-pTR GFP-RasV12, MDCK-pTR cSrcY527F-GFP, MDCK-pTR scribble shRNA, MDCK-pTR GFP-RasV12 EPLIN shRNA and MDCK-pTR filamin A shRNA cells were cultured as previously described 10, [14] [15] [16] . To establish MDCK-pTRE3G Myc-RasV12 cells, complementary DNA of Myc-HRasV12 was cloned into BamHI/EcoRI sites of pPB-TRE3G-MCS-CEH-rtTA3-IP, which was constructed by introducing the TRE3G promoter with cloning sites, insulator and rtTA3-expressing elements into a PiggyBac-based vector (SBI). MDCK cells were then transfected with pPB-TRE3G Myc-RasV12 by nucleofection (nucleofector 2b Kit L, Lonza), followed by selection in medium containing 5 µg ml −1 blasticidin (Invitrogen). MDCK-pTRE3G Myc-RasV12 cells stably expressing FLII 12 Pglu-700µδ6 (ref. 49) were established by co-transfecting MDCK cells with pPB-TRE3G Myc-RasV12 and pPB-FLII 12 Pglu-700µδ6, followed by the same selection method as above. To establish MDCK-pTR GFP-RasV12 cells stably expressing PDK4 shRNA, LDHA shRNA or luciferase shRNA, or MDCK cells stably expressing PDH shRNA or luciferase shRNA in a tetracycline-inducible manner, each shRNA sequence was cloned into the BglII/XhoI site of pSUPER.neo + gfp (for the former three shRNAs) or pSUPERIOR.neo + gfp (for the latter two shRNAs) (Oligoengine). Sequences of shRNAs are listed in Supplementary Table 1. For tetracycline-inducible MDCK cell lines, 2 µg ml −1 of tetracycline (Sigma-Aldrich) was used to induce expression of proteins or shRNAs except for MDCK-pTRE3G Myc-RasV12 cells, for which 1 µg ml −1 of doxycycline (Sigma-Aldrich) was used. MDCK-pTR filamin A shRNA cells were incubated with tetracycline for 48 h to induce sufficient knockdown prior to co-incubation with MDCK-pTR GFP-RasV12 cells. For immunofluorescence, cells were plated onto collagen gel-coated coverslips. Type I collagen (Cellmatrix Type I-A) was obtained from Nitta Gelatin and was neutralized on ice to a final concentration of 2 mg ml −1 according to the manufacturer's instructions. The CellTracker dyes CMTPX (red dye), CMFDA (green dye) and CMAC (blue dye) (Life Technologies) were used according to the manufacturer's instructions. CRISPR/Cas9-based generation of PDK4-knockout cells. Guide sequences of PDK4 single-guide RNA 1 (sgRNA1) and sgRNA 2 targeting Canis PDK4 were designed on exons 1 and 9, respectively, as described previously 50 . PDK4 sgRNA sequences (PDK4 sgRNA1, 5 -GCTTCGTGATGCGCAGCGC-3 ; PDK4 sgRNA2, 5 -ACGGCACCAACGCCTGTGA-3 ) were introduced into the pCDH-EF1-Hygro-sgRNA vector 51 using primers listed in Supplementary Table 1 . First, MDCK cells were infected with lentivirus carrying pCW-Cas9 as described 51 , and were cultured in the 500 ng ml −1 puromycin-containing medium. The tetracyclineinducible MDCK-Cas9 cells were transfected with the pCDH-EF1-PDK4 sgRNA1 and 2 by nucleofection, followed by selection in medium containing 200 µg ml −1 of hygromycin, and subjected to limiting dilution. Indels on the PDK4 exons in each monoclone were analysed by direct sequencing using primers listed in Supplementary Table 1 . To generate PDK4-deleted cells carrying doxycyclineinducible GFP-RasV12, pPB-TRE3G GFP-RasV12 was introduced into the PDK4-deleted cells by nucleofection and antibiotic selection. In addition to the PDK4 −/− MDCK-pTRE3G GFP-RasV12 cells, we generated PDK4 +/+ MDCK-pTRE3G GFPRasV12 cells as a control cell line.
Mice. All animal experiments were conducted under the guidelines by the Animal Care Committee of Hokkaido University. The animal protocols were reviewed and approved by the Hokkaido University Animal Care Committee (approval number 12-0116). We used 6-10 week old C57BL/6 mice of either sex. To establish DNMT1-CAG-loxP-STOP-loxP-HRas V12 -IRES-eGFP knock-in mice, the genomic fragments of the DNA methyltransferase 1 (DNMT1) locus, the loxP-flanked stop and neomycin resistance cassette, cDNA encoding HRas V12 plus frt-flanked IRES-eGFP and the diphtheria toxin subunit A gene were inserted into the targeting vector. The resulting plasmid DNA was linearized and electrophoretically transfected into IB10 ES cells. Recombinant alleles were verified by Southern blot analysis. The independent clones were each injected into blastocysts of C57BL/6 mice and were successfully transmitted through the germline, and DNMT1-CAG-loxP-STOP-loxP-HRas V12 -IRES-eGFP mice (acc. no. CDB0706K: http://www2.clst.riken.jp/arg/mutant%20mice%20list.html) were thus established. villin-Cre ERT 2 mice 52 were crossed with DNMT1-CAG-loxP-STOPloxP-HRas V12 -IRES-eGFP mice or CAG-loxP-STOP-loxP-eGFP mice 53 to create villin-RasV12-GFP or villin-GFP mice respectively. Mice heterozygous for each transgene were used for experiments. For PCR genotyping of mice, primers listed in Supplementary Table 1 were used. The expected sizes of PCR products were 220 base pairs (bp), 403 bp and 390 bp for villin-Cre ERT 2 , DNMT1-CAG-loxP-STOPloxP-HRas V12 -IRES-eGFP and CAG-loxP-STOP-loxP-eGFP mice, respectively. To culture intestinal organoids, isolated crypts from the mouse small intestine were entrapped in Matrigel (Corning) and plated in a non-coated 35 mm glass-bottom dish as previously described 36 . The crypts embedded in Matrigel were covered with Advanced DMEM/F12 supplemented with N2 (Invitrogen), B27 (Invitrogen), 50 ng ml −1 EGF (PeproTech), 100 ng ml −1 Noggin (PeproTech), 1.25 mM N -acetylcysteine (Sigma-Aldrich) and R-spondin conditioned medium collected from 293T-HA-Rspol-Fc cells provided by Dr Calvin Kuo (Stanford University). After 96 h culture, organoids were incubated with tamoxifen (Sigma) for 24 h to induce transgenes. Subsequently, tamoxifen was washed out, and organoids were cultured for the indicated times for analyses. For in vivo experiments, 6-10 weeks old villin-RasV12-GFP or villin-GFP mice were given a single intraperitoneal injection of 2 mg of tamoxifen in corn oil (Sigma), and were then sacrificed at 2, 3, 5 or 7 days after Cre activation. To examine the effect of DCA, the mice were first pretreated with 5.0 g l −1 DCA in the drinking water for 2 weeks. Subsequently, the mice were injected intraperitoneally with 2.0 mg of tamoxifen and sacrificed 3 days later; DCA was continuously administered during this period. The iGT (intestinespecific gene transfer) experiments were carried out as previously described 37 . Briefly, 3-5 cm regions of small intestine drawn out from the peritoneal cavity were tied with nylon string. 300 µl of the mucus removing solution (20 mM DTT, 0.05% Tween-20 in PBS) was injected into the intestinal lumen for 15 min, removed and incubated with the same solution for 10 min. After washing with PBS three times by pipetting, 300 µl of the transfection solution containing Cy3-labelled siRNA and HVJ-E was injected, and the mice were left for 1 h. The sequences of scramble and PDK4 siRNA are listed in Supplementary Table 1. 2.0 mg of tamoxifen was injected into the peritoneal cavity when the wound was sutured. The mice were killed for analysis after 3 days of iGT.
Immunofluorescence and western blotting. For immunofluorescence, MDCK-pTR GFP-RasV12, MDCK-pTR cSrcY527F-GFP, MDCK-pTR scribble shRNA, MDCKpTRE3G Myc-RasV12, MDCK-pTR GFP-RasV12 PDK4 shRNA, MDCK-pTRE3G GFP-RasV12 PDK4 sgRNA, MDCK-pTR PDH shRNA, MDCK-pTR GFP-RasV12 EPLIN shRNA, MDCK-pTR GFP-RasV12 LDHA shRNA or MDCK-pTR GFPRasV12 luciferase shRNA cells were mixed with MDCK, MDCK-pTR filamin A shRNA or MDCK-pTR luciferase shRNA cells at a ratio of 1:50 and plated onto collagen-coated coverslips as previously described 10 . The mixture of cells was incubated for 8-12 h, followed by tetracycline or doxycycline treatment for 16 h, except for analyses of apical extrusions, which were examined after 24 h of tetracycline or doxycycline addition. Cells were fixed with 4% paraformaldehyde (PFA) in PBS and permeabilized as previously described 11 . All primary antibodies were used at 1:100, and all secondary antibodies were used at 1:200. To monitor the mitochondrial activity or superoxide production, cells were loaded with 50 nM TMRM or 5 µM MitoSOX respectively for 30 min and subjected to microscopic observation or quantitatively analysed with a CellInsight image cytometer (Thermo Fisher Scientific). As to TMRM, we have thoroughly checked and optimized the experimental conditions. After titration of TMRM concentration, we chose 50 nM, which provides clear and sufficient fluorescence intensity. By checking the effect of oligomycin and FCCP, we confirmed that the experimental condition is under the non-quenching mode using 50 nM TMRM 54 . We also confirmed that 2 µg ml −1 tetracycline did not affect TMRM fluorescence. The ratiometric images of TMRM and MitoTracker Green were obtained by incubating cells with 200 nM MitoTracker Green for 2 h, briefly washed, and then loaded with 50 nM TMRM. The 2-NBDG uptake was examined by incubating cells with glucose-free DMEM for 2 h followed by addition of 100 µM 2-NBDG for 30 min. For immunofluorescence using intestinal organoids, cells grown in Matrigels were incubated with Cell Recovery Solution (Corning) for 8 min before fixation with 4% PFA. After fixation, cells were permeabilized in 0.5% Triton X-100/PBS for 1 h and blocked in 1% BSA/PBS for 1 h. For immunohistochemical examinations of the small intestine, the tissues were isolated and fixed in 4% PFA, dehydrated and embedded in paraffin. Microsections of each specimen were placed on glass slides, de-paraffinized and processed for immunostaining. The iGT-operated small intestine was embedded in OCT compound (Tissue-Tek), and frozen sections (10 µm) were cut on a cryostat. Immunofluorescence images were analysed with the Olympus FV1000 or FV1200 system and Olympus FV10-ASW software. Images were quantified with the MetaMorph software (Molecular Devices). Western blotting was carried out as previously described 55 . Primary antibodies were used at 1:1,000. The western blotting data were analysed using ImageQuant LAS4010 (GE Healthcare).
FRET analysis. Glucose FRET experiments were carried out as previously described 56 . In brief, MDCK-pTRE3G Myc-RasV12 cells stably expressing FLII 12 Pglu-700µδ6 were co-cultured with MDCK cells at a ratio of 1:50 or cultured alone on a collagen gel in 35 mm diameter, glass-bottom dishes (Matsunami Glass). At 16 h after doxycycline addition, a differential interference contrast (DIC) image and cyan fluorescent protein (CFP) and FRET fluorescence images were recorded. FRET efficiency was calculated as a quotient of background-subtracted FRET and CFP images and is presented in an intensity-modified display mode with the MetaMorph software. In the intensity-modified display mode, eight colours from red to blue are used to represent the FRET efficiency. To evaluate the ATP level, MDCK-pTRE3G Myc-RasV12 cells were transiently transfected with ATeam probe 57 , stained with CMTPX, and co-cultured with MDCK cells at ratio of 1:50 or cultured alone on a collagen gel in 35 mm diameter, glass-bottom dishes. At 16 h after doxycycline addition, FRET efficiency was examined as described above.
Time-lapse microscopic observation. For ex vivo time-lapse analyses, intestinal organoids grown in Matrigels were incubated with 100 nM tamoxifen for 24 h to induce transgenes. Subsequently, time-lapse observation was carried out for 24 h in the medium containing no tamoxifen by Nipkow spinning disk confocal microscopy (X-Light; Crest Optics). Fluorescence images (853 × 720 pixels, 0.975 µm resolution) were captured at an exposure of 0.25 s. Images of 42 µm depth in the z-axis were obtained at 3 µm z-steps.
For intravital imaging of small intestine in living mice, mice were anaesthetized with isoflurane, the small intestine was surgically exposed, and then villi were observed using two-photon excitation microscopy. Intestinal lumen was visualized with 70 kDa tetramethylrhodamine-conjugated dextran (Sigma). Nuclei of cells were stained with intravenous injection of Hoechst 33342 (Life Technologies) just before imaging. The imaging system was composed of a two-photon microscope (A1-MP; Nikon) driven by a laser (Chameleon Vision II Ti:sapphire; Coherent) tuned to 880 nm and an inverted microscope equipped with a ×20 objective lens (Plan Fluor; numerical aperture 0.75; Nikon). Fluorescent signals were detected through bandpass emission filters at 525/50 nm (for GFP) and at 575/25 nm (for tetramethylrhodamine). Raw imaging data were processed using Imaris software (Bitplane).
Electron microscopy. MDCK-pTR GFP-RasV12 cells were cultured alone or cocultured with MDCK cells in collagen-gel-coated, grid-imprinted plastic dishes (µ-Dish 35 mm Grid-500, Ibidi Corporation). After tetracycline treatment for 24 h, cells were fixed in 2% glutaraldehyde in HEPES buffer (30 mM HEPES, 0.1 M NaCl and 2 mM CaCl 2 (pH 7.4)), and fluorescence and DIC images of GFP-RasV12 cells and the surrounding cells were captured together with the underlying, numbered grid information. Cells were then post-fixed in 2% osmium tetroxide in 0.1 M imidazole (pH 7.4) and stained with 1% uranyl acetate (UA) before being dehydrated and embedded in Araldite-Epon resin (Electron Microscopy Sciences). During these procedures, GFP fluorescence was lost, but the grid was imprinted onto the resin. Subsequently, GFP-RasV12 cells and the two or three rows of surrounding MDCK cells were selected and excised, while referring to the grid information, morphology of the cells and captured images. Ultrathin sections of the trimmed sample were poststained with UA and lead citrate, and cells were imaged with an electron microscope (JEM-1400; JEOL) operating at 80 kV.
Quantitative real-time PCR. MDCK-pTR GFP-RasV12 cells or a 10:1 mixed culture of MDCK and MDCK-pTR GFP-RasV12 cells were cultured at a density of 2 × 10 7 cells on collagen-coated 15 cm dishes (Greiner-Bio-One). After incubation with tetracycline for 16 h, GFP-positive RasV12 cells and GFP-negative MDCK cells were separated with an analytical flow cytometer. Total RNA was extracted from the isolated cells using Trizol (Thermo Fisher Scientific) and an RNeasy Mini Kit (QIAGEN) and reverse transcribed using a QuantiTect Reverse Transcription Kit (QIAGEN). GeneAce SYBR qPCR Mix (NIPPON GENE) was used to perform qPCR using the StepOne system (Thermo Fisher Scientific). The primer sequences used are listed in Supplementary Table 1 . We used β-actin as a reference gene to normalize data.
Lactate assay. For lactate assay, MDCK cells, MDCK-pTR GFP-RasV12 cells, MDCK-pTR GFP-RasV12 LDHA shRNA cells or a 1:1 mix of MDCK and MDCKpTR GFP-RasV12 or MDCK-pTR GFP-RasV12 LDHA shRNA cells were cultured at a density of 6.5 × 10 5 cells on collagen-coated 12-well dishes (Falcon) in DMEM containing neither phenol red nor fetal calf serum. The culture medium was replaced with fresh medium at 12 h after tetracycline addition and collected 12 h later. Samples were subjected to measurement of lactate concentration using a lactate assay kit (BioVision).
HIF1 reporter assay. MDCK or MDCK-pTR GFP-RasV12 cells were co-transfected with pCDH/5HRE-Luc (provided by Dr Hiroshi Harada (Kyoto University)) and pRL-TK. After 24 h, cells were trypsinized, and cultured alone or co-cultured with the indicated cells (total cell number: 3.5 × 10 5 ) for 8 h, followed by tetracycline treatment for 16 h. Firefly luciferase activity was measured using a dual-luciferase reporter assay (Promega) and normalized by Renilla luciferase activity.
Statistics and reproducibility. For data analyses, unpaired two-tailed Student t-tests were used to determine P-values. P-values less than 0.05 were considered to be significant. No statistical method was used to predetermine sample size. For animal studies, the experiments were not randomized, and the investigators were not blinded to allocation during experiments. All results were reproduced with at least two independent experiments and at least three mice of each genotype. Figs 1a,b, 3c ,e,f,h,j, 4i, 5c and 7a) or four repeats ( Fig. 7f and Supplementary Fig. 3g ). The experiment of Supplementary Fig. 6b was carried out once, but homologous recombination in ES cells was confirmed by PCR. Figs 1b,f, 2b,d,f, 3a ,c,e,g,i, 4c,e, 5b,c,f, 6c, 7b,c,e,h and 8c,f,k and Supplementary Figs 1e,h, 3l ,n, 4c,g, 5f,g,i, 6c and 7d,e have been provided as Supplementary Table 2. All data supporting the findings of this study are available from the corresponding author on request.
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